NGL Fine-Chem Limited

Healthcare›Healthcare›Pharmaceuticals & Biotechnology›Pharmaceuticals

Ask AI

Key metrics

Price as of 2026-07-17

Stock price
₹3131.90
Market cap
1,935 Cr
Stock P/E
35.5
P/B
5.88
Dividend yield
0.1%

Sign in for full ratios and TTM. Learn about these metrics →

Share price

NSE closing price from historical market data.

Loading price history…

Statement tables · Consolidated

Switches quarterly, P&L, balance sheet, and cash flow. Key metrics and ratios stay on consolidated when available.

Amounts in ₹ Cr · NSE preferred when both exchanges report the same period · tap + to expand rows

Quarterly results

Quarterly · ₹ Cr · tap + rows to expand

MetricJun 2023Sept 2023Dec 2023Mar 2024Jun 2024Sept 2024Dec 2024Mar 2025Jun 2025Sept 2025Dec 2025Mar 2026
Sales71 Cr80 Cr88 Cr100 Cr91 Cr93 Cr89 Cr95 Cr104 Cr120 Cr128 Cr149 Cr
Operating expenses (approx.)61 Cr66 Cr74 Cr84 Cr81 Cr82 Cr84 Cr89 Cr93 Cr103 Cr105 Cr128 Cr
EBITDA10 Cr14 Cr14 Cr16 Cr9 Cr12 Cr5 Cr6 Cr11 Cr17 Cr22 Cr21 Cr
OPM %13.9%17.4%15.8%15.9%10.3%12.4%5.7%6.7%10.5%14.3%17.5%14.3%
Other income3 Cr3 Cr4 Cr4 Cr6 Cr5 Cr-0.13 Cr-0.97 Cr6 Cr2 Cr5 Cr2 Cr
Interest0.24 Cr0.36 Cr0.28 Cr0.49 Cr0.44 Cr0.32 Cr0.60 Cr0.97 Cr1 Cr1 Cr1 Cr1 Cr
Depreciation3 Cr3 Cr3 Cr3 Cr3 Cr3 Cr3 Cr3 Cr4 Cr5 Cr5 Cr5 Cr
Profit before tax10 Cr14 Cr14 Cr16 Cr12 Cr13 Cr1 Cr1 Cr12 Cr13 Cr21 Cr18 Cr
Tax %15.6%24.8%30.0%23.4%21.8%26.4%-0.9%48.7%22.0%25.7%24.1%24.3%
Net profit9 Cr10 Cr10 Cr12 Cr9 Cr10 Cr1 Cr0.54 Cr9 Cr10 Cr16 Cr13 Cr
EPS (₹)₹13.77₹16.96₹16.24₹19.95₹14.92₹15.88₹2.07₹0.88₹14.96₹15.58₹25.40₹21.83

Profit & loss (annual)

Annual · last column is TTM · ₹ Cr · tap + to expand

MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026TTM
Sales152 Cr258 Cr318 Cr278 Cr339 Cr368 Cr501 CrSign in for TTM
Operating expenses (approx.)132 Cr178 Cr250 Cr244 Cr285 Cr334 Cr428 CrSign in for TTM
EBITDA19 Cr80 Cr68 Cr34 Cr53 Cr34 Cr73 CrSign in for TTM
OPM %12.8%30.9%21.4%12.3%15.7%9.2%14.5%Sign in for TTM
Other income3 Cr8 Cr11 Cr6 Cr14 Cr9 Cr15 CrSign in for TTM
Interest2 Cr2 Cr2 Cr1 Cr1 Cr2 Cr4 CrSign in for TTM
Depreciation8 Cr8 Cr10 Cr11 Cr12 Cr12 Cr20 CrSign in for TTM
Profit before tax12 Cr78 Cr67 Cr27 Cr54 Cr28 Cr63 CrSign in for TTM
Tax %31.0%26.9%25.1%25.1%24.1%23.8%24.1%Sign in for TTM
Net profit8 Cr57 Cr50 Cr20 Cr41 Cr21 Cr48 CrSign in for TTM
EPS (₹)₹13.49₹91.81₹80.77₹33.18₹66.88₹34.19₹77.90Sign in for TTM
Dividend payout %——2.2%5.3%2.6%5.1%2.2%Sign in for TTM
Sign in for TTM

Trailing twelve months totals and margin rows

Balance sheet

Annual · ₹ Cr · tap + rows to expand

MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Equity capital3 Cr3 Cr3 Cr3 Cr3 Cr3 Cr3 Cr
Reserves96 Cr151 Cr200 Cr219 Cr260 Cr277 Cr326 Cr
Borrowings23 Cr11 Cr27 Cr30 Cr32 Cr73 Cr108 Cr
Other liabilities32 Cr42 Cr47 Cr34 Cr60 Cr78 Cr108 Cr
Total liabilities154 Cr208 Cr277 Cr287 Cr356 Cr433 Cr545 Cr
Fixed assets (net)67 Cr64 Cr88 Cr88 Cr85 Cr142 Cr164 Cr
CWIP—12 Cr6 Cr26 Cr46 Cr50 Cr95 Cr
Investments11 Cr29 Cr29 Cr39 Cr54 Cr60 Cr39 Cr
Other assets81 Cr125 Cr173 Cr163 Cr213 Cr235 Cr276 Cr
Total assets154 Cr208 Cr277 Cr287 Cr356 Cr433 Cr545 Cr

Cash flows

Annual · ₹ Cr · tap + rows to expand · last column includes FCF

MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
Cash from operating activity——14 Cr35 Cr20 Cr36 Cr43 Cr
Cash from investing——-14 Cr-27 Cr-27 Cr-35 Cr-71 Cr
Cash from financing——-1 Cr-1 Cr-1 Cr-1 Cr30 Cr
Net cash flow——-1 Cr7 Cr-7 Cr0.19 Cr2 Cr
Free cash flow (OCF − Capex)——-43 Cr4 Cr-8 Cr-95 Cr-47 Cr

Ratios

Ratios as reported or derived per annual period.

MetricMar 2020Mar 2021Mar 2022Mar 2023Mar 2024Mar 2025Mar 2026
ROCE %9.3%43.2%25.0%9.1%14.1%6.0%12.1%
ROE %8.4%0.0%0.0%0.0%0.0%7.5%0.0%
Debtor days63537386978195
Inventory days1461371208493102103
Days payable109107807710611595
Cash conversion cycle10083114948468103
Debt / equity0.230.070.130.140.120.260.33
Current ratio1.882.952.642.792.461.981.84
Net debt / EBITDA1.160.110.390.660.602.141.45

Compare with peers

Loading peers…